Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Strategy To Optimize PeriproCeduraL AnticOagulation in Structural Transseptal Interventions

NCT05305612 is registered in ClinicalTrials.gov with National Institute of Cardiology, Warsaw, Poland as lead sponsor.

NCT NCT05305612
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05305612 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Strategy To Optimize PeriproCeduraL AnticOagulation in Structural Transseptal Interventions
Lead sponsor
National Institute of Cardiology, Warsaw, Poland
Phase
Phase 4
Overall status
Enrolling by invitation
Start date
March 13, 2022
Completion date
March 31, 2027
Enrollment
410 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulation, atrial fibrillation, mitral regurgitation